Loading clinical trials...
Loading clinical trials...
Evaluation of Concordance Between an Innovative Test on Exhaled Air (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2 in Symptomatic Patients or Closed Contacts
Conditions
Interventions
eBAM Cov Testing
Locations
2
France
Laboratoire Alphabio, Hôpital Européen Marseille
Marseille, France
CHU de NIMES
Nîmes, France
Start Date
January 1, 2025
Primary Completion Date
June 1, 2026
Completion Date
June 1, 2026
Last Updated
March 24, 2025
NCT06631287
NCT06850350
NCT04565665
NCT04978571
NCT06082518
NCT07221162
Lead Sponsor
Centre Hospitalier Universitaire de Nīmes
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions